Lauren P. Silvernail
Net Worth

Last updated:

What is Lauren P. Silvernail net worth?

The estimated net worth of Ms. Lauren P. Silvernail is at least $6,149,779 as of 18 May 2022. She owns shares worth $1,005,154 as insider, has earned $1,345,545 from insider trading and has received compensation worth at least $3,799,080 in Evolus, Inc..

What is the salary of Lauren P. Silvernail?

Ms. Lauren P. Silvernail salary is $633,180 per year as Chief Financial Officer & Executive Vice President of Corporation Devel. in Evolus, Inc..

How old is Lauren P. Silvernail?

Ms. Lauren P. Silvernail is 67 years old, born in 1958.

What stocks does Lauren P. Silvernail currently own?

As insider, Ms. Lauren P. Silvernail owns shares in one company:

Company Title Shares Price per share Total value
Evolus, Inc. (EOLS) Chief Financial Officer & Executive Vice President of Corporation Devel. 141,571 $7.1 $1,005,154

What does Evolus, Inc. do?

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

EOLS logo
EOLS
Evolus, Inc.
$7.1

Lauren P. Silvernail insider trading

Evolus, Inc.

Ms. Lauren P. Silvernail has made 7 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently she sold 52,015 units of EOLS stock worth $646,026 on 18 May 2022.

The largest trade she's ever made was exercising 52,015 units of EOLS stock on 18 May 2022. As of 18 May 2022 she still owns at least 141,571 units of EOLS stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 52,015 $12.42 $646,026
Sale
Common Stock 16,189 $13.92 $225,351
Sale
Common Stock 10,192 $9.73 $99,117
Sale
Common Stock 14,293 $11.18 $159,781
Sale
Common Stock 14,293 $11.18 $159,781
Sale
Common Stock 2,699 $7.46 $20,135
Sale
Common Stock 2,612 $13.54 $35,353

Evolus key executives

Evolus, Inc. executives and other stock owners filed with the SEC:

  • Dr. Rui Avelar Dip.SportMed, M.D., C.CFP (63) Chief Medical Officer and Head of R&D
  • Mr. David Moatazedi (47) Pres, Chief Executive Officer & Director
  • Ms. Lauren P. Silvernail (67) Chief Financial Officer & Executive Vice President of Corporation Devel.